← All stocks

LifeStance Health Group, Inc.

LFST Net selling
CIK 0001845257 #1389 in the set updated 17 Sep 2026
Bought (120 mo)
$498.29K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.48B
$14.16M on a plan · $0.00 straight out of an exercise
Sold at will
$1.46B
119 of 148 sales
Net
−$1.48B
−$1.46B against sales at will

By person

35 insiders · 153 transactions
23.3×

David Bourdon holds 23.3 times base salary in stock. $15.34M of shares against $657.69K in salary for 2025.

Salary from the company's own proxy. The shares are what David Bourdon last reported holding, valued at $12.29, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
TPG GP A, LLC entity
10% owner
$828.81M (5)
−$828.81M
177,793,109
46.54%
$2.19B
−35.0%
BLACK DARREN M.
Director
$185.27M (6)
−$185.27M
23,310,115
6.10%
$286.48M
TPG Group Holdings (SBS) Advisors, Inc. entity
10% owner
$163.61M (2)
−$163.61M
175,284,635
45.88%
$2.15B
−5.2%
SUMMIT PARTNERS L P entity
10% owner
$107.71M (4)
−$107.71M
75,457,073
19.75%
$927.37M
−16.3%
Summit Partners Growth Equity Fund IX-A, L.P. entity
10% owner
$65.08M (3)
−$65.08M
41,932,358
10.98%
$515.35M
−13.1%
Silversmith Partners I GP, LLC entity
Member of 10% Group
$46.02M (4)
−$46.02M
14,324,197
3.75%
$176.04M
−30.5%
CRISAN JEFFREY
Director
$27.81M (3)
−$27.81M
17,916,554
4.69%
$220.19M
Bessler Robert
Director
$16.99M (28) scheduled
−$16.99M
731,925
0.1916%
$9.00M
−71.2%
Mullins Kevin Michael
Chief Development Officer
$11.30M (23)
−$11.30M
4,650,571
1.22%
$57.16M
−18.6%
Burdick Kenneth A
Director
$498.29K (5)
$7.10M (2)
−$6.60M
3,017,321
0.7898%
$37.08M
Gouk Warren
Chief Administrative Officer
$4.49M (21)
−$4.49M
5,818,204
1.52%
$71.51M
−7.2%
Qureshi Danish J.
See Remarks
$3.45M (8)
−$3.45M
5,266,943
1.38%
$64.73M
+7.3%
Shuey Eric
Director
$1.95M (1)
−$1.95M
961,544
0.2517%
$11.82M
−13.4%
Lester Michael K.
President and CEO
$1.75M (1)
−$1.75M
23,148,931
6.06%
$284.50M
−0.2%
Pardo Ryan
See Remarks
$1.44M (6)
−$1.44M
1,093,366
0.2862%
$13.44M
+136.8%
Miller Lisa K
Chief Operating Officer
$1.10M (4)
−$1.10M
281,289
0.0736%
$3.46M
−0.4%
Paunovich Vukasin
Chief Technology Officer
$1.02M (2)
−$1.02M
205,379
0.0538%
$2.52M
Pantaleoni Pablo
Chief Digital Officer
$666.05K (5)
−$666.05K
1,450,503
0.3797%
$17.83M
+70.7%
Varanakis Ann
Chief People Officer
$528.07K (4)
−$528.07K
413,881
0.1083%
$5.09M
+457.6%
Cipollone Paula
See Remarks
$484.66K (4)
−$484.66K
239,915
0.0628%
$2.95M
+12.6%
Booth Gwen H.
Chief Operating Officer
$467.97K (1)
−$467.97K
7,083,637
1.85%
$87.06M
−0.2%
Bourdon David
Chief Executive Officer
$407.66K (1)
−$407.66K
1,248,247
0.3267%
$15.34M
DeLuca Teresa
Director
$345.09K (2)
−$345.09K
133,456
0.0349%
$1.64M
+267.0%
Bruff Jesse Michael
Chief Financial Officer
$146.50K (2)
−$146.50K
1,928,369
0.5047%
$23.70M
+2.8%
Ramtekkar Ujjwal
Chief Medical Officer
$144.25K (2)
−$144.25K
103,916
0.0272%
$1.28M
Patel-Dunn Anisha
Chief Medical Officer
$98.31K (3)
−$98.31K
277,055
0.0725%
$3.41M
+1,178%
Gorcyca Felicia
Chief People Officer
$14.06K (1)
−$14.06K
909,582
0.2381%
$11.18M
+8.8%
McGroarty Ryan
See Remarks
772,235
0.2021%
$9.49M
+112.8%
Miller William Joseph
Director
459,880
0.1204%
$5.65M
+14.5%
Verma Seema
Director
137,811
0.0361%
$1.69M
Eken Stephanie Carin
Chief Medical Officer
115,107
0.0301%
$1.41M
Personette Sarah
Director
92,512
0.0242%
$1.14M
Palmer Eric P
Director
89,174
0.0233%
$1.10M
Goltermann Lori
Director
35,492
0.0093%
$436.20K
Justice Thurman
Director
35,492
0.0093%
$436.20K
Insider
Date
Role
Action
Shares
Price
Amount
Burdick Kenneth A
11 Aug 2025
Director
Buy
18,660
$4.54
$84.72K
Burdick Kenneth A
11 Aug 2025
Director
Buy
1,340
$4.35
$5.83K
Burdick Kenneth A
8 Aug 2025
Director
Buy indirect
46,511
$4.30
$200.00K
Burdick Kenneth A
8 Aug 2025
Director
Buy
1,800
$4.31
$7.76K
Burdick Kenneth A
8 Aug 2025
Director
Buy
45,870
$4.36
$199.99K

What was left out

Form 4 filings counted 216
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 18
Sales on a Rule 10b5-1 plan 29
Sales straight out of an exercise 0
Sales at will 119
Transactions with no price 0
Shares from compensation/vesting 84,717,666
Sales filed before the plan box existed 41
History held since 16 Jun 2021